Cynosure (NSDQ:CYNO) shareholders last week filed a class-action lawsuit to halt the company’s proposed $1.44 billion sale to Hologic (NSDQ:HOLX), alleging that Cynosure’s regulatory filing recommending the transaction is missing crucial information about the company’s financial projections and the process that led up to the deal.
The complaint, filed in the U.S. District Court for Massachusetts, suggested that the filing is misleading and that shareholders don’t have enough information to ensure the proposed transaction is a good deal.
Get the full story at our sister site, MassDevice.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]